New OncodriveFM release 0.3.2
Some time ago Abel wrote about how to identify cancer drivers from tumor somatic mutations, and presented OncodriveFM. Nuria also posted a nice poster explaining it together [...]
Oncogenomics workshop: my slides on the analysis of Somatic Mutations in IntOGen
Last week I attended the Oncogenomics Workshop in Hinxton. This was a really interesting Workshop organized by the Industry program of the EBI. It addressed the issues [...]
New IntOGen Somatic Mutations Analysis version available
We are proud to announce the brand new version of the IntOGen Somatic Mutations Analysis (IntOGen SM) pipeline. We call it version 2.0.0 as it has been completely [...]
Gitools in GenomeSpace and a new user mail list
As some already may know, Gitools has been integrated with GenomeSpace. Together with the GenomeSpace team we have set up a tutorial that demonstrates the power behind [...]
Oncodrive-CIS: a method to reveal likely driver genes based on the impact of their copy number changes on expression.
One of the current challenges of oncogenomics is to elucidate which of the aberrations observed in the cancer genome is involved in the disease and which of [...]
How to visualize multidimensional cancer genomics data?
A challenge to all cancer genomic studies is to visually explore the generated complex data in a meaningful way to extract relevant knowledge. We have written a review on [...]
Gitools 1.8 for improved data managament and transfer
We have started to distribute Gitools in the version 1.8.x. This latest version include important new features in terms of communication of Gitools with other tools (i.e. [...]
How to prioritize cancer somatic mutations?
Projects that sequence the genomes of a cohort of tumor samples are faced with the challenge of deciding which somatic mutations are relevant to tumor development (drivers). [...]
Systematic identification of cancer drivers across tumor types in IntOGen
This post is to share with you the poster describing “Systematic identification of cancer drivers across tumor types in IntOGen” that was presented last week at the Cambridge [...]
